Cedrik Britten

Cedrik Britten

Company: Immatics

Job title: Chief Medical Officer


Driving Clinical Activity of TCR-T Cells in the Challenging Solid Tumour Setting 11:00 am

Developing TCR-engineered T-cells against PRAMEpositive solid tumours Leveraging the power of TCR-T cells: safety and antitumour activity of TCR-T cells directed against PRAMEpositive solid tumours Potentiating anti-tumour activity through CD8αβ cotransduction Tackling the tumour microenvironment by next generation TCR-T cells directed against a novel tumour stroma targetRead more

day: Day 1 – Track B – Morning

Industry Leaders’ Fireside Chat – Setting a Trailblazing Fire to the Cell Therapy Field with Next Generation Approaches 9:00 am

An executive panel discussion from the industry leaders of the field to set the scene on next generation CAR-TCR therapies. Ask your questions live to understand the expert’s thoughts on key topics including: Successes and hurdles to date: T-cell therapy translation to solid tumours, non-oncologic disorders and off-the-shelf (ex vivo and in vivo) T-cell engineering…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.